Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Integra LifeSciences Holdings Corporation

Stage 3 · Topping · week 7

As of Oct 22, 2026, Integra LifeSciences Holdings is in Stage 3, the topping phase, now in week 7 (since Sep 9, 2026). It closed at $12.33, 37.9% below its 52-week high and below its 200-day average, which is rising.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. More about the company

$12.33
+4.14% today
$959M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is IART early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S1 16w
S4 19w
S4 26w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 1w → S1 5w → S4 11w → S1 8w → S2 4w → S3 2w → S4 18w → S1 3w → S4 13w → S1 16w → S4 1w → S3 4w → S4 19w → S1 12w → S4 26w → S1 4w → S2 13w → S3 6w current
Total tracked: 165 weeks across 18 stage runs.

IART among Medical Devices64th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…64IARTStage 3 · wk 738−20.6%
vs 52W High
-37.9%
$8.90 lo$19.85 hi
37.9% below 52W high, weakening from peak
The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.
Stage Maturity
Week 7
1w13w26w
Week 7, distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-12.5%
200 DMA: $14.09 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
1.49x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-20.6%
3M
-37.7%
6M
+19.5%
YTD
+2.7%
1Y
-22.4%
Scan Membership
Breakout Watch
Latest: 2024-02-08
6 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S3
Wk 7 · Vol 1.49x
2026-10-21S3
Wk 7 · Vol 2.01x
2026-10-20S3
Wk 6 · Vol 1.46x
2026-10-19S3
Wk 6 · Vol 0.81x
2026-10-16S3
Wk 6 · Vol 0.94x
2026-10-15S3
Wk 6 · Vol 1.53x
2026-10-14S3
Wk 6 · Vol 1.28x
2026-10-13S3
Wk 5 · Vol 0.94x
2026-10-12S3
Wk 5 · Vol 1.02x
2026-10-09S3
Wk 5 · Vol 1.39x
2026-10-08S3
Wk 5 · Vol 1.61x
2026-10-07S3
Wk 5 · Vol 1.56x
Moving averages & range
50 DMA
$15.47
200 DMA
$14.09
52W High
$19.85
52W Low
$8.90
5D Low
$11.84
Resistance levels (recent highs)
20d High
$16.64
60d High
$18.34
120d High
$19.85
250d High
$19.85
Next resistance
+35.0%
to 20d High
P/E (TTM)
72.5
Forward 5.2
Dividend Yield
0.00%
P/B 0.9

Integra LifeSciences Holdings: quick answers

What stage is Integra LifeSciences Holdings in?

As of Oct 22, 2026, Integra LifeSciences Holdings (IART) is in Stage 3, the topping phase. It entered Stage 3 on Sep 9, 2026 and is in week 7. What the four stages mean

Is Integra LifeSciences Holdings in an uptrend?

Its uptrend has stalled. Integra LifeSciences Holdings is in Stage 3, the topping phase that follows an advance. It trades 12.5% below its 200-day average, which is rising.

How far is Integra LifeSciences Holdings from its 52-week high?

Integra LifeSciences Holdings closed at $12.33 on Oct 22, 2026, 37.9% below its 52-week high of $19.85. Its 52-week low is $8.90.

How has Integra LifeSciences Holdings performed over the past year?

As of Oct 22, 2026, Integra LifeSciences Holdings is down 22.4% over the past year and up 2.7% so far in 2026.

Which sector and industry is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.